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Summary for different forms of the disorder (Keating and San-
guinetti 1996). The dilated cardiomyopathies are often
Barth syndrome (BTHS) is an X-linked disorder charac-
idiopathic, and in adults they represent a primary indica-
terized clinically by the associated features of cardiac
tion for heart transplantation. Less frequent and more
and skeletal myopathy, short stature, and neutropenia.
severe are the infantile forms, which often cause cardiac
The clinical manifestations of the disease are, in general,
failure during the ﬁrst months of life. One of these severe
quite variable, but cardiac failure as a consequence of
forms is Barth syndrome (BTHS), an X-linked inherited
cardiac dilatation and hypertrophy is a constant ﬁnding
disorder characterized clinically by the associated fea-
and is the most common cause of death in the ﬁrst
tures of cardiac and skeletal myopathy, short stature,
months of life. X-linked cardiomyopathies with clinical
and neutropenia (Barth et al. 1983). The disease has
manifestations similar to BTHS have been reported, and
infantile onset of symptoms and is often fatal in child-
it has been proposed that they may be allelic. We have
hood, because of cardiac failure or sepsis: the clinical
recently identiﬁed the gene responsible for BTHS, in one
manifestations of the disease are, in general, quite vari-
of the Xq28 genes, G4.5. In this paper we report the
able also within families, but cardiac failure as a conse-
sequence analysis of 11 additional familial cases: 8 were
quence of cardiac dilatation and hypertrophy is a con-
diagnosed as possibly affected with BTHS, and 3 were
stant ﬁnding. Which of the other manifestations of the
affected with X-linked dilated cardiomyopathies. Muta-
disease may also be diagnostic is an open question. X-
tions in the G4.5 gene were found in nine of the patients
linked infantile cardiomyopathies with cardiac dilata-
analyzed. The molecular studies have linked together
tion but apparently lacking the other symptoms of BTHS
what were formerly considered different conditions and
have been reported, and it has been proposed that the
have shown that the G4.5 gene is responsible for BTHS
BTHS may be allelic with both X-linked endocardial
(OMIM 302060), X-linked endocardial ﬁbroelastosis
ﬁbroelastosis (EFE1; OMIM 305300) and other infan-(OMIM 305300), and severe X-linked cardiomyopathy
tile cardiomyopathies (Gedeon et al. 1995; OMIM(OMIM 300069). Our results also suggest that very se-
300069).vere phenotypes may be associated with null mutations
BTHS has been localized to Xq28 (Bolhuis et al.in the gene, whereas mutations in alternative portions or
1991). We have recently reported the identiﬁcation of amissense mutations may give a ‘‘less severe’’ phenotype.
novel gene, G4.5, which we have proposed as the genetic
locus responsible for the disease (Bione et al. 1996). The
Introduction G4.5 gene is a small single-copy gene with a complex
pattern of expression. As many as 10 mRNAs differingThe dilated cardiomyopathies are a very heterogeneous
either in the region encoded in the central exons (5–7)group of heart disorders of largely unknown ethiology.
or in the 5 end can be synthesized. Two forms, con-Genetic causes have become increasingly evident with
taining all three exons or lacking exon 5 only, weremapping of loci and identiﬁcation of genes responsible
consistently more abundant and ubiquitously expressed.
Since the differently spliced mRNAs maintain the same
open reading frame (ORF), the tafazzins, the putativeReceived March 28, 1997; accepted for publication July 11, 1997.
Address for correspondence and reprints: Dr. Daniela Toniolo, proteins encoded by the gene, can differ in the N-termi-
IGBE-CNR, Via Abbiategrasso 207, 27100 Pavia, Italy. E-mail: nus and in a central portion. All the mutations found
Toniolo@ipvgbe.igbe.pv.cnr.it
in the four familial cases of BTHS studied so far have 1997 by The American Society of Human Genetics. All rights reserved.
0002-9297/97/6104-0013$02.00 introduced a stop codon in the ORF, but in all instances
862
863D’Adamo et al.: X-Linked Dilated Cardiomyopathies
they would not interfere with the synthesis of all the two of the patients (BS and GW) and seems to have
increased life expectancy.possible tafazzins. We now report the study of a larger
group, of patients affected with BTHS and of patients In the search for mutations, PCR products were pre-
pared from genomic DNA of either one patient or anaffected with severe cardiac disorders compatible with
X-linked inheritance. We show that mutations are to be obligate carrier from each family and were sequenced
directly, as described elsewhere (Bione et al. 1996). Mu-found also in this group of patients and that the G4.5
gene is responsible for most of the X-linked infantile tations were found in six of the familial cases, and they
are listed in table 1; their localizations with respect todilated cardiomyopathies.
the G4.5 gene are shown in ﬁgure 1. Some of the corre-
sponding sequences are shown, aligned with the normalMaterial and Methods
sequence, in ﬁgure 2.
Mutation Detection Two new mutations were found in exon 2, one was
in exon 6, and the remaining three were in exon 8. OneGenomic DNA preparation, ampliﬁcation, and direct
sequencing of the BTHS gene were as described else- of the mutations in exon 2 (family 1) was a deletion
causing a frameshift and early stop; all the remainingwhere (Bione et al. 1996). Sequences were from the
primers described, and they were designed to sequence mutations were missense. As a control for polymor-
phism, 100 chromosomes from normal individuals wereall exons and exon-intron junctions from both strands.
As a control for PCR errors, at least two independent sequenced in the region of the mutations, and they were
all normal. On the other hand, additional affected indi-PCR products were sequenced in the region of each mu-
tation. The sequence of each patient was always com- viduals and obligate carriers, when available, were se-
quenced, and the mutations were all conﬁrmed. In fam-pared with that of at least one normal individual, in
the same gel. As a control for polymorphism, all the ily 1 we sequenced the mother’s DNA; in family 6 the
mother’s and the grandmother’s DNAs; in family 8 themutations were searched in DNA from 100 normal
chromosomes randomly selected among different popu- mother’s and the sister’s DNAs; and in family 9 the
mother’s, the aunt’s, and a normal brother’s DNAs.lations available to the laboratory and containing both
males and females. In the remaining two families, published as putative
BTHS (families 11 and 12; O¨rstavik et al. 1993), no
Sequence Analysis mutations were found. Since only the coding region and
Sequence reactions were run in a Perkin Elmer 373A the splice junctions were studied, and since only the
Automated Sequencer, and they were analyzed by use DNAs of obligate carriers were available, we cannot
of SeqEd and Sequence Navigator software. Sequences absolutely exclude an involvement of the G4.5 gene.
were compared with the GenBank sequences by use of Four sporadic patients were also studied, and no muta-
BLAST, and they were aligned with CLUSTAL. tions were found.
X-Linked Infantile Cardiomyopathies: Mutations in theResults
BTHS Gene
Mutation Analysis of BTHS Patients Gedeon et al. (1995) reported a large family present-
ing with X-linked inheritance of a fatal infantile cardio-In our previous work we studied patients from four
families affected with BTHS. To gain more information myopathy. The gene was mapped to Xq28. The cardio-
myopathy in this family is consistently of congenitalon the mutations causing this disorder, we collected
eight additional cases. Some were deﬁnitely familial. In onset and is fatal in infancy. The clinical features were
insufﬁcient to permit a deﬁnite diagnosis, but the possi-other families relatives were reported as possibly af-
fected, but the disease could not be well deﬁned before bility that this disease is allelic with BTHSwas discussed.
We sequenced the G4.5 gene in two affected individualsdeath occurred. Some of the clinical manifestations of
the propositi of each family are schematically listed in of the family, and we found deletion of a C at position
919 in exon 8, causing frameshift and a stop codon aftertable 1. Other affected family members were usually
studied less thoroughly and are not reported in the table: 18 nucleotides (patient MH in ﬁg. 1). The mutation may
cause the production of a truncated protein or, possibly,some of the families were previously published, and
more data are available from the literature. In all fami- a reduced amount of the corresponding mRNAs and
therefore no protein at all (Maquat 1995).lies, cardiac dilatation and cardiac failure within the
1st year of life were the common feature. Neutropenia We have also studied patients from two families with
several affected male relatives (brothers and cousins)(usually cyclic or episodic), myopathy, growth retarda-
tion, and alterations in urinary 3-methylglutaconic acid who died very early of heart failure. The clinical data
were very limited, but after autopsy these patients’(Kelley et al. 1991) were consistently reported. Life ex-
pectancy was very variable, possibly depending on medi- hearts showed left-ventricular dilatation and hypertro-
















Data on BTHS Patients
Age at Dilated 3-
Source Affected Year of Age Death Cardio- Methylglutaconic Growth Abnormal
Family Patient Author Relative(s) Referencea Birth (years) (mo) myopathyb Neutropeniab Myopathyb Aciduriab Retardationb Mitochondriab Mutation Exon Referencea
1 BM R.M. Brother . . . 1986 10 Living / Cyclic / / / ND 428del13 2 . . .
2 V.22 P.A.B. Several (18) 1 1984 10 / / //0 / / / Y51X 2 5
3 BS M.A.P. Two brothers 2 1992 5 Living /c //0 //0 / / ND H69Q 2 . . .
4 K P.A.B. Not proved . . . 1989 13 / 0 / //0 / ND 527-1 GrA 5
5 GW A.G. Nephew . . . 1978 19 Living /d Cyclic 0 / / / 527-1 GrC 5
6 FW K.H.O. Brother 3 1984 9 / / ND ND / ND F178Ie 6 . . .
7 OAT A.G. Several 4 1989 ú21 / / / ND ND ND 868insT 7 5
8 MF M.A.D. Not proved . . . 1994 14 / / ND / ND ND G197R 8 . . .
9 FT P.A.B. Not proved . . . 1991 5 Living / Cyclic / / / ND G216R 8 . . .
10 BV P.A.B. Not proved . . . 1983 16 Living / / / / / ND G216R 8 . . .
11 II-1 K.H.O. Brother 3 1987 1 / 0 //0 ND 0 /f Nonee . . .
12 II-2 K.H.O. Brother 3 1977 20 / 0 0 ND 0 /f Nonee . . .
a 1 Å Barth et al. (1983); 2 Å Patton et al. (1994); 3 Å O¨rstavik et al. (1993); 4 Å A`des et al. (1993); and 5 Å Bione et al. (1996).
b / Å Present; 0 Å absent; //0 Å uncertain status; and ND Å not done.
c Cardiac transplant at age 4 mo.
d Cardiac transplant at age 14 mo.
e Sequence was determined on the basis of the mother’s DNA.
f Only in myocardium.
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Figure 1 Mutations in G4.5 gene, and their localization in a schematic representation of the gene. Blackened boxes are invariant exons;
and diagonally striped boxes are alternatively spliced exons.
One family was published by Lindenbaum et al. in 1973 ﬁrst 3–4 mo of life of cardiac failure. The fourth, SWH
(IV-4), had cardiac failure at age 5 wk, survived, and(Lindenbaum et al. 1973). In the second large and yet-
unpublished family (ﬁg. 3), four affected males were now, at age 25 years, is normal. In both families we
found the same mutation (a GrA change at nucleotidedescribed: three (IV-1, IV-16, and V-5) died within the
1006) in exon 10, causing a GrR change in the sequence
of the protein (G240R). The mutation was not found
in 100 normal chromosomes. In the family studied by
Lindenbaum et al., the mutation was found in three
obligate carriers. In the family of SWH, all the patients
and the mother (II-1) of SWH were sequenced and
shown to carry the mutation.
Missense Mutations: Change of Conserved Amino
Acids
The G4.5 gene is conserved in evolution. A BLAST
search of GenBank showed that ORFs encoding very
similar protein sequences exist in Caenorhabditis ele-
gans and Saccharomyces cerevisiae genomes. The align-
ment of the tafazzins from the three organisms is shown
in ﬁgure 4. The region corresponding to the alternative
exon 5 in human is missing in the C. elegans gene; in S.
cerevisiae the corresponding region is present, but it is
not conserved. Striking conservation was observed in
most of the rest of the protein. The four regions boxed
in ﬁgure 4 are the most conserved: ú50% of the amino
acids are identical between the three species, and ú80%
are conservative substitutions. The missense mutations
found in the patients are indicated in ﬁgure 4, and in all
instances they correspond to residues conserved between
two or all three organisms. No function is known for
the C. elegans or S. cerevisiae tafazzins, since they corre-
spond to ORFs identiﬁed by genomic sequencing.
Figure 2 Portions of chromatograms showing mutations in some
Discussionpatients (BM, BS, and MF [bottom sections of panels]) or in an obligate
carrier (HM [bottom section of panel]), compared with the normal se-
In this paper we have presented the results of a studyquence (top sections of panels). Lowercase letters denote intron sequences.
of mutations in the BTHS gene, G4.5. We show thatNumbers correspond to nucleotide positions in the cDNA (Bione et al.
1996). Arrowheads point to mutations. A 13-base deletion is boxed. mutations in this gene are found in BTHS and in other
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affected with either EFE1 or severe cardiomyopathy have
not been as thoroughly studied, and they were just de-
scribed as affected with dilated cardiomyopathy.Whether
the other symptoms of BTHS were present cannot be
established with the available clinical data, but our ﬁnd-
ings suggest that mutations in the G4.5 gene have to be
considered as a possible cause of infantile dilated cardio-
myopathies affecting males, even in the absence of the
typical BTHS signs.
Seven different mutations have been reported in this
work. They were searched and not found in 100 normal
Figure 3 Pedigree of family SWH. The asterisk (*) indicates the chromosomes, and, when DNA of family members was
‘‘normal’’ male (II-4) carrying the mutation. Blackene boxes denote available, they were shown to segregate with the disease.
affected males; and diagonally striped boxes denote males who died The 11 mutations described thus far in the BTHS gene
of heart disorder different from BTHS.
are null or missense mutations localized in alternative,
as well as in invariant, parts of the gene. Both missense
and null mutations seem to be responsible for a similar
X-linked dilated cardiomyopathies, previously considered disease, since the clinical characteristics and life expec-
different conditions and listed with different OMIM tancy of the patients in each BTHS family do not appear
numbers (305300 and 300069). The patients diagnosed to profoundly differ. This is unlike the situation in many
as affected with BTHS were often well characterized, and other disorders, where missense often causes a pheno-
at least one patient in each family was thoroughly studied. type less severe than that caused by null mutations.
We have tried to summarize the most common features However, since comparison with similar sequences in
of the disease, and the data in table 1 demonstrate that, distant species has indicated that the amino acids
in addition to cardiac failure in the 1st year of life, growth changed by the mutations are highly conserved residues,
arrest, cyclic neutropenia, and methylglutaconic aciduria the very severe effect of missense mutations could be
ascribed to a drastic structural modiﬁcation of the pro-appear to be reliable diagnostic signs of BTHS. Patients
Figure 4 Alignment of amino acid sequence of tafazzins with C. elegans and S. cerevisiae homologues, done by use of CLUSTAL. Asterisks
(*) indicate identical amino acids; and dots indicate conserved amino acids. Highly conserved regions are boxed; and amino acids changed in
the patients indicated are in boldface.
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